CLINICAL_TRIALS
research
· 2026-04-16
Clinical Trial Update: Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis [NA]
Summary
A dose-escalation study of stereotactic radiosurgery for brain metastases is currently active but not recruiting, sponsored by UT Southwestern Medical Center.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Brain Neoplasms, Adult, Malignant | NA | Status: ACTIVE_NOT_RECRUITING